1,080 Lung Injury Cases and 18 Deaths Associated with Using E-cigarettes or Vaping Products

This editorial is written by Jeffrey Rosen, Founder and President of Tailored Benefits, Inc.
A refrain you may hear from a Cheech & Chong movie: “Hey man, like no one has ever died from marijuana.”  Well, times are a changing. 
Given that vaping is promoted as a “better” alternative smoking method, it seems that real research, other than by vaping companies themselves, should be confirming, or denying said claims.
The news has been awash with vaping related illnesses. According to the CDC, “As of October 1, 2019, 1,080 lung injury cases associated with using e-cigarette, or vaping, products have been reported to CDC from 48 states and 1 U.S. territory. Eighteen deaths have been confirmed in 15 states.” 

For comparison sake and a dash of perspective, 130 Americans die per day, of opioid related illnesses while 480,000 from nicotine related causes. That being said, something needs to be done about consumer safety.

RELATED:  What are GMO Cookies Seeds?

It is important to understand and distinguish the issues between nicotine and cannabis vaping. 

As the New York Times reported, in 2009 the FDA knew that nicotine vaping was an emerging trend in society and then, spent the next decade either sitting on their hands or fighting against the powerful tobacco lobby which won 2 cases against the FDA in 2009 to push back time frames for regulation. 

In 2013, former Director of CDC, Dr. Thomas Frieden, stated that “once you saw cotton candy flavors, everything that could have been done to get them off the market should have been done.”  It was not.

As to Cannabis, we live in a regulatory vacuum, each state creating their own rules and regulations. 

Thirty six (36) states permit medical use and eleven states have passed adult use laws, fully legalizing it.
RELATED:  Which States Have Recreational Marijuana Dispensaries?
There are few studies being done on the safety of vaping THC oils/extracts, with specific base mixes, additives, or blends.
This regulatory vacuum is similar to when neutraceuticals were launched with little oversight.   

At this point, the Federal government needs to step up and lead.  With Federal legalization of cannabis, the industry would over time come under uniformly consistent rules and regulations.  

Equally important with Federal legalization, in addition to banking and the allowance of 280E, would be the increased enforcement against black market operators which has been found to be responsible for many of the cannabis vaping illnesses.

RELATED:  Buying Weed In Canada: Things to Know

The illegal cannabis market in CA is said to be 3 to 1 over licensed sales.  Much ink has been spent on Weedmaps’ continued allowance of thousands of illegal operations to advertise and sell their illegal wares on their platform. 
In reviewing Weedmaps’ database, the The LA times reported finding a total of 3,757 listing for dispensaries or delivery services of which 2,835 were illegal. 
For perspective, the government was able to crack down and eliminate the “personals” section from Craigslists which promoted prostitution in a relatively quick time frame. 

Weedmaps has been doing this for years whereas a policy requiring a valid state license prior to advertising would have seemed fundamental to running a legal site.  Weedmaps has reported they are working on an end of the year solution.

Without legalization, we are left with state to state regulations which, among other deficiencies, does not always incorporate consumer protection and the integrity of a product.

RELATED:  State Medical Marijuana Laws (Updated)

As this is new territory, the Federal and state governments will need to take a more rigorous consumer safety approach.  In the interim, cannabis companies need to step up quality assurance to insure clean products.
Cannabis businesses need to be leaders in rigorous quality control, safety and education.  Failure to do so will lead to an ever increasing amount of product liability lawsuits, of which there are already quite a few.  Plaintiff’s class action lawsuits have already occurred in the cannabis industry and will only increase. 

That being said, on the insurance side, a cannabis company should always expend the necessary resources to cover for all potential liabilities. 

RELATED:  What Are Medical Marijuana Vape Cartridges?

Sources

Author Bio: Jeffrey Rosen Is The Founder  & President  of Tailored Benefits, Inc. 
Tailored Benefits, Inc. is one of the premier
Employee benefit and consulting firms in Northern California.

His experiences resolving company benefit and employee related issues led him to instill an advocacy approach to Tailored Benefits’ client services. This approach to client management assures continuous delivery of highly professional and personalized employee benefit services.  With over a decade of experience as a practicing attorney, Jeffrey’s understanding of the legal nuances in insurance services informs every aspect of his business practice. Jeffrey brings an unprecedented level of entrepreneurship, management expertise, and innovation to the regulated cannabis insurance and benefits industries.



Keep exploring...

Boveda: Why Correct Humidity is Crucial in Storing Cannabis

We interview, Charles Rutherford II, Business Development Director of Boveda, @BovedaInc the importance of the correct humidity in storing cannabis.   Charles answers the following questions...

Zane Witzel: Designing High-End Storage for Cannabis

Zane Witzel is the CEO and Founder of @cannador. His company manufactures and sells uniquely designed, high-end storage products and accessories in the cannabis lifestyle...

Related Articles

16 Governors Urge Congress to Pass the SAFE Banking Act for Cannabis

Sixteen Democratic governors, led by Maryland Gov. Wes Moore, asked Congress to pass the SAFE Banking Act for state-licensed cannabis businesses.

DEA and Rescheduling Opponents File Final Briefs Over GAO Report

The DEA and rescheduling opponents filed final reply briefs on Nov. 5 over a GAO report. Here is what each side argued and what comes next from the judge.

DEA Proposes 2027 Production Quotas: Marijuana Held Flat, Psychedelics Rise

DEA's proposed 2027 quotas hold Schedule I marijuana flat and raise MDMA and ibogaine, with Schedule III cannabis quotas still to come. Comments open 30 days.

Texas Appeals Court Cancels Hemp Rule Arguments After Election Shakes Up the Bench

The Texas Fifteenth Court of Appeals canceled its Dec. 8 argument in the hemp THC rules case after voters replaced all three of its justices. What it means.

Pennsylvania and Wisconsin Flip Legislatures: What It Means for Marijuana Legalization

Democrats flipped the Pennsylvania Senate and both Wisconsin chambers on Nov. 3. Here is what changed for marijuana legalization and what still stands in the way.

Massachusetts Voters Reject Question 8, Keeping Legal Cannabis Sales in Place

Massachusetts voters rejected Question 8, keeping adult-use cannabis sales legal. Unofficial results, plus Idaho and Houston measures.

AMA Tells FDA Cannabis and Kratom Need Drug-Level Evidence, Backs a Research “Special Schedule”

The AMA told the FDA that cannabis and kratom should meet the same evidence standards as other drugs, while backing a federal special schedule to ease marijuana research.

Marijuana Users and Guns: What a New Poll Shows and What the Hemani Ruling Left Open

A new poll says 26% of cannabis consumers are more likely to buy a gun after the Supreme Court's Hemani ruling. Here is what the decision did and did not decide.